Suscribirse

LIPOPOLYSACCHARIDE RECOGNITION, CD14, AND LIPOPOLYSACCHARIDE RECEPTORS - 08/09/11

Doi : 10.1016/S0891-5520(05)70078-7 
Robin R. Ingalls, MD *, Holger Heine, PhD *, Egil Lien, PhD *, Atsutoshi Yoshimura, PhD *, Douglas Golenbock, MD *

Resumen

A common and serious consequence of overwhelming bacterial infections is the development of septic shock and associated organ failure. The pathogenesis of the shock is presumed to be secondary to excessive stimulation of host cells by microbial constituents, which are potent activators of inflammatory cytokine synthesis. Although activation of cytokine synthesis is an important component of the innate immune response to infection, excessive cytokine production is likely an important mechanism of lethal septic shock. In the case of gram-negative sepsis, the pathogenesis of the shock is presumed to be secondary to excessive stimulation of host cells by bacterial lipopolysaccharide (LPS) endotoxin, a glycolipid that constitutes the major portion of the outermost membrane of gram-negative bacteria.56, 64, 65 This leads to the synthesis and release of proinflammatory cytokines, arachidonic acid metabolites, and various other mediators, which in turn mediate the systemic toxicity. LPS is an extremely potent toxin: macrophages can be activated at concentrations of LPS as low as 1 pg/mL. Despite the numerous medical advances that have occurred over the past 30 years, the outcome of gram-negative sepsis has remained relatively unchanged, with a mortality rate around 35%.57 Greater insight into the nature of host interactions with LPS is essential before we can hope to design effective antisepsis therapies.

The lipid A portion of LPS is conserved among gram-negative bacteria and appears to be responsible for the biologic toxicity of LPS.64, 66 Three cloned molecules expressed on the surface of monocytes and macrophages are known to bind the lipid A moiety of LPS. These include CD14, the macrophage scavenger receptor (SR), and the β2 (CD11/CD18) leukocyte integrins. The scavenger receptor does not appear to function as a signaling receptor for LPS, although studies of scavenger receptor knockout mice have demonstrated a role for the scavenger receptor in host defense.27, 72 In contrast, both CD1432, 93 and CD11/1836, 37 are capable of initiating intracellular signals, resulting in phagocyte activation, bacterial internalization (phagocytosis, endocytosis), and the activation of bactericidal defenses. In addition, CD14 and the CD11/CD18 integrins interact with LPS in conjunction with serum proteins, including soluble CD14 (sCD14) and LPS-binding protein (LBP). These soluble LPS receptors enhance the sensitivity of the membrane-bound receptors to LPS by 100- to 1000-fold.

In addition to the receptors described above, two additional ones, Toll-like receptor (TLR)-2 and TLR-4, have recently been implicated in LPS signaling. These human homologues of Toll, a protein first identified during the study of embryonic development in Drosophila melanogaster, have been linked to innate immunity and may play a role in the primitive activation pathway induced by LPS.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Robin R. Ingalls, MD, The Maxwell Finland Laboratory for Infectious Diseases, 774 Albany Street, Boston, MA 02118


© 1999  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 13 - N° 2

P. 341-353 - juin 1999 Regresar al número
Artículo precedente Artículo precedente
  • STRUCTURE-FUNCTION RELATIONSHIPS OF BACTERIAL ENDOTOXINS : Contribution to Microbial Sepsis
  • David C. Morrison, Richard Silverstein, Michael Luchi, Alexander Shnyra
| Artículo siguiente Artículo siguiente
  • VACCINES AND ANTIBODIES IN THE PREVENTION AND TREATMENT OF SEPSIS
  • Apurba K. Bhattacharjee, Alan S. Cross

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.